Keywords
How to Cite
Abstract
Sickle cell disease (SCD) comprises an inherited blood disorder that is life long and affects many people globally. Despite progress in therapy, SCA is a considerable cause of mortality and morbidity. This study was designed to measure the immunological and inflammatory parameters of patients with sickle cell disease (SCD) and to found if there is any role of it in the pathogenicity of the disease. This study included A total of 32 patients, their ages ranged from 16 to 55 years patients with Sickle cell disease who have been evaluated during vaso occlusive crisis and had been followed up till they attained steady state, and there are 32 normal control subjects matched with patients in age and sex. In general there was elevation in all parameters the study were included in patients than control and particularly in crisis, despite the IgM value which was insignificantly decrease, but the statically significant elevation reported only in CRP, IgG, IgA.
References
McEwen B S. The neurobiology of stress: From serendipity to clinical relevance. Brai. Rese. Bull, 2000; 886: 172- 189.
Segerstrom SC. and Miller GEP .sychological stress and the human immune system: A meta-analytic study of 30 years of inquiry. Psychol. Bull, 2004; 130: 601- 630.
Krishnan S. Setty Y. Betal SG. Vijender V. Rao, K. Dampier C. and Stuart M. Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vaso-occlusive crises. Br. J. Haematol.2010; 148: 797-804.
Chong Y. Ikematsu H. and Yamaji K. (CD27 (+) )memory) B cell decrease and apoptosis-resistant CD27 (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances. Int. Immunol.2005; 17:383-90.
Milalrd D DE, Ceulaer K. Vaidy S. and Sergeant G.R. Serum immunolglobin levels in children with hymozygous sicklee cell disease. Clin. Chim. Acta.1982; 125: 81-87.
Venkataraman M. and Westerman M P. B-cell changes occur in sickle cell anaemia. Am. J. Clin. Path.1985; 84: 153- 159.
Janeway C. and Travers P. Immunology. The immune system in health and disease. 3rd ed.1997; London: Churchill Livingstone.
Larcher V F. Wyke R J. Defective yeast opsonisation and functional deficiency of complement in sickle cell disease. Arch. Dis. Child.1982; 57: 343-6.
Boghossian S H. Wright G. Webster D B. and Segal A W. Investigation of host defence in patients with sickle cell disease. Br. J. Haematol.1985; 59: 523-531.
Bargoma E M. Mitsuyoshi J K. Larkin S K. Styles L A. Kuypers, F A. and Test S.T. Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vaso-occlusive crisis or acute chest syndrome. Blood,2005; 105: 3384-3385.
Stuart J. Stone P C W. Akinola N O .Monitoring the acute phase responseto vaso-occlusive crisis insickle cell disease. J Clin. Patho.1994; 47: 166-9.
Rees D C. and Gibson J S. Biomarkers in sickle cell disease. Br. J. Haematol.2011; 156: 433-445.
Anyaegbu C C. Okpala I E. Aken’ova A Y. And Salimonu L S. Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia. APMIS,1999; 107: 699-702.
14- Salihcetiner T F. akoilij Y. Emelakoglu K. And Metinkomi D. Immunological Studies in Sickle Cell Disease: Comparison ofHomozygote Mild and Severe Variants. Clin. Immu. and Immunop,1989; 53: 37-39.
Adeodu O O. Adekile A D. Jeje, A A. and Adedeji F A. Serum Immunoglobulins A and M in sickle cell patients inIle-Ife. E Afr. Med. J.1989; 66: 631-5.
Malave I. Escalona E. Perdomo Y. In vitro antibody synthesis by peripheralblood mononuclear cellsfrom patients with sickle cell disease. Acta Haematol.1990; 84: 89-94.
Catherine B A. Baba I B .and Stephen K O. Infection in sickle cell disease: A review. Intern. J. of Infec. Disea, 2010;14: e2-e12.
This work is licensed under a Creative Commons Attribution 4.0 International License.